DrugPatentWatch Database Preview

Cumberland Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for CUMBERLAND PHARMS, and what generic alternatives to CUMBERLAND PHARMS drugs are available?

CUMBERLAND PHARMS has four approved drugs.

There are sixteen US patents protecting CUMBERLAND PHARMS drugs.

There are ninety patent family members on CUMBERLAND PHARMS drugs in twenty-five countries.

Summary for Cumberland Pharms

International Patents:	90
US Patents:	16
Tradenames:	5
Ingredients:	4
NDAs:	4

Drugs and US Patents for Cumberland Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cumberland Pharms	CALDOLOR	ibuprofen	SOLUTION;INTRAVENOUS	022348-002	Jun 11, 2009		RX	Yes	Yes	9,295,639
Cumberland Pharms	ACETADOTE	acetylcysteine	INJECTABLE;INTRAVENOUS	021539-001	Jan 23, 2004	AP	RX	Yes	Yes	8,722,738
Cumberland Pharms	LACTULOSE	lactulose	FOR SOLUTION;ORAL	074712-002	Dec 10, 1997		RX	No	Yes

Paragraph IV (Patent) Challenges for CUMBERLAND PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Injection	200 mg/mL, 30 mL vials		2012-04-04

International Patents for Cumberland Pharms Drugs

Country	Document Number	Estimated Expiration
Brazil	PI0925034
European Patent Office	2453742
Canada	2167673

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Cumberland Pharms
• Cumberland Swan